Company Filing History:
Years Active: 2015
Title: Jörg Benz: Innovator in Chymase Binding Compounds
Introduction
Jörg Benz is a notable inventor based in Rheinfelden, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptide binding compounds. His work has implications for medical applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Jörg Benz holds a patent for "Chymase binding compounds and medical uses thereof." This invention relates to a polypeptide that binds to chymase (EC 3.4.21.39). The polypeptide comprises an amino acid sequence with various specified components, allowing for flexibility in its application. The patent highlights the potential for these compounds in therapeutic settings, emphasizing their importance in medical research.
Career Highlights
Jörg Benz is associated with Covagen AG, a company that focuses on innovative biopharmaceuticals. His work at Covagen AG has positioned him as a key player in the development of novel therapeutic solutions. His expertise in polypeptide technology has contributed to advancements in the field.
Collaborations
Jörg has collaborated with notable colleagues, including Simon Brack and Sarah Batey. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jörg Benz's contributions to the field of biochemistry through his innovative patents and collaborations underscore his role as a leading inventor. His work continues to influence medical research and therapeutic applications.